Why the study?
The number of pregnant women with heart disease is increasing, requiring objective data on perinatal outcomes, management, and existing lacunas to provide better care and inform patient choices.
Do pregnant women with heart disease have worse perinatal outcomes compared to pregnant women without heart disease?
Do pregnant women with heart disease have worse perinatal outcomes compared to pregnant women without heart disease?
Pregnant women with heart disease are at a significantly higher risk for adverse perinatal and neonatal outcomes, emphasizing the need for specialized multidisciplinary care and informed patient counseling.
Answers are grounded in this paper and cite their sources.
May support closer perinatal surveillance in maternal heart disease; leaves open prospective trials of targeted interventions.
With improved technology and better access to health care, the number of pregnant women with heart diseases is increasing. Due to various physiological changes in pregnancy, women with heart diseases are at increased risk of both maternal and fetal complications. Thus, pregnancy with heart disease is considered a high-risk pregnancy. In the near future, the burden on the healthcare system will increase and we will be required to answer various questions about the different outcomes possible and their management. If women are made aware of the various risks associated with their pregnancies, they can make informed life choices. This can only be achieved if more objective data is offered to her.[1] In this article, we review the available data on the observed perinatal outcomes in mothers with heart disease, their management, and what lacunas need to be filled, so as to be able to provide better care. Relevant articles were referred and data was summed. We concluded that in the majority of studies, the odds for adverse neonatal outcomes like preterm birth, low birth weight, stillbirth, low Apgar score and admissions to neonatal intensive care unit were higher among pregnant women with heart disease as compared to women with no heart disease.
No takes yet. Share an insight, caveat, or question.
Kedia et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: